There are 2137 resources available
445P - Real-world evidence (RWE) on the clinical outcomes in 1st-line chemotherapy (CT) for fit and vulnerable patients (pts) with metastatic colorectal cancer (mCRC)
Presenter: Kentaro Yamazaki
Session: E-Poster Display
Resources:
Abstract
446P - Real-world data (RWD) survival analysis of first line (1L) metastatic colorectal cancer (mCRC) patients (pts) with BRAF V600 and non-V600, KRAS G12 and G13, and NRAS mutations
Presenter: Anda Gershon
Session: E-Poster Display
Resources:
Abstract
447P - Long term survival with regorafenib: REALITY (real life in Italy) trial - A GISCAD Study
Presenter: Eleonora Lai
Session: E-Poster Display
Resources:
Abstract
448P - Predictive factor of cardiotoxicity in fluoropyrimidine-treated colorectal cancer patients: Interim analysis of the prospective observational CHECKPOINT trial
Presenter: Giacomo Aimar
Session: E-Poster Display
Resources:
Abstract
449P - Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial)
Presenter: Pamela Baldin
Session: E-Poster Display
Resources:
Abstract
450P - The impact of late-line treatment on overall survival (OS) from the initiation of first-line chemotherapy (CT) for patients (pts) with metastatic colorectal cancer (mCRC): Updated analysis
Presenter: Takeshi Kawakami
Session: E-Poster Display
Resources:
Abstract
451P - Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients
Presenter: Pau Riera
Session: E-Poster Display
Resources:
Abstract
452P - A phase Ib dose escalation study of binimetinib plus mFOLFIRI in patients with metastatic RAS mutated colorectal cancer
Presenter: Vaia Florou
Session: E-Poster Display
Resources:
Abstract
453P - QUAlity of LIfe and survival of meTAStatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS)
Presenter: Patricia Hamers
Session: E-Poster Display
Resources:
Abstract
454P - Comparative study of metronomic capecitabine and oxaliplatin versus classic XELOX in Egyptian patients with metastatic colorectal cancer
Presenter: Raghda Abu El Ela
Session: E-Poster Display
Resources:
Abstract